Clinical Trial Detail

NCT ID NCT01281514
Title Carboplatin, Pegylated Liposomal Doxorubicin Hydrochloride, and Everolimus in Treating Patients With Relapsed Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
Recruitment Completed
Gender female
Phase Phase I
Variant Requirements No
Sponsors Fox Chase Cancer Center
Indications

peritoneal carcinoma

ovarian carcinoma

fallopian tube carcinoma

Therapies

Carboplatin + Everolimus + Pegylated liposomal-doxorubicin

Age Groups: adult

No variant requirements are available.